## Abstract The frequency of radiocontrast administration is dramatically increasing, with over 80 million doses delivered annually worldwide. Although recently developed radiocontrast agents are relatively safe in most patients, contrast nephropathy (CN) is still a major source of in‐hospital and
B-Natriuretic Peptide for the Prevention of Radiocontrast-Induced Nephropathy
✍ Scribed by Desikan Kamalakannan; Rakesh Lattupalli; Nancy Mesiha; Michelle Ganoff; Susan Steigerwalt; Robert Provenzano; Quresh Khairullah; Howard Rosman
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2008
- Tongue
- English
- Weight
- 83 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0090-2934
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract This study was undertaken to examine the possible role of the DNA‐binding activity of nuclear factor‐kappa B (NF‐κB) in rat of radiocontrast‐media‐induced nephropathy (RCIN) and to explore the characteristic of RCIN in rats and the role of NF‐κB in its occurrence. Forty‐eight adult male
## Abstract C‐type natriuretic peptide (CNP) stimulates the differentiation and inhibits the proliferation of osteoblastic lineage cells. In this study, we examined whether the effects of CNP on osteoblastic functions change with aging using calvarial osteoblast‐like cells from 25‐week‐old (young)
The aim of our studies was to investigate hormonal prevention of hepatic preservation damage by the atrial natriuretic peptide (ANP) and the mechanisms involved. Isolated perfusion of rat livers was performed in a nonrecirculating fashion. Twenty minutes of preischemic perfusion was performed with o